(PDF) Once-Daily Netarsudil vs Twice-Daily Timolol in

Once-Daily Netarsudil vs Twice-Daily Timolol in Patients With Elevated Intraocular Pressure, the Randomized Phase 3 ROCKET-4 Study

American Journal of Ophthalmology - Netherlands

doi 10.1016/j.ajo.2019.03.002

Full Text

Open PDF

Abstract

Available in full text

Date

August 1, 2019

Authors

Leonard Robert Cacioppo

Jeffrey Raymond Lozier

Robert John Smyth-Medina

Thomas Richard Walters

David L. Wirta

Publisher

Elsevier BV

Amanote Research

Once-Daily Netarsudil vs Twice-Daily Timolol in Patients With Elevated Intraocular Pressure, the Randomized Phase 3 ROCKET-4 Study

American Journal of Ophthalmology - Netherlands

doi 10.1016/j.ajo.2019.03.002

Full Text

Abstract

Categories

Date

Authors

Publisher

Related search

Tafluprost Once Daily for Treatment of Elevated Intraocular Pressure in Patients With Open-Angle Glaucoma

Latanoprost Administered Once Daily Caused a Maintained Reduction of Intraocular Pressure in Glaucoma Patients Treated Concomitantly With Timolol.

Comparison of Once Daily Versus Twice Daily Olmesartan in Patients With Chronic Kidney Disease

Trough to Peak Ratio of Once-Daily Lisinopril and Twice-Daily Captopril in Patients With Essential Hypertension

A Randomized Trial of Once vs Twice Daily Administration of Intravenous Granisetron With Dexamethosone in Patients Receiving High-Dose Cyclophosphamide, Thiotepa and Carboplatin

Fluticasone Furoate: Once-Daily Evening Treatment Versus Twice-Daily Treatment in Moderate Asthma

Comparisons Between Twice-Daily and Once-Daily Training Sessions in Male Weight Lifters

Efficacy and Safety of Once-Daily QVA149 Compared With the Free Combination of Once-Daily Tiotropium Plus Twice-Daily Formoterol in Patients With Moderate-To-Severe COPD (QUANTIFY): A Randomised, Non-Inferiority Study

Improved Adherence With Once-Daily Versus Twice-Daily Dosing of Mometasone Furoate Administered via a Dry Powder Inhaler: A Randomized Open-Label Study